Want to see AIFC full AI Analyst Report?
AIFC Stock Chart & Stats
$1.18
-$0.89(-13.09%)
At close: 4:00 PM EST
$1.18
-$0.89(-13.09%)
Day’s Range― - ―
52-Week Range$0.52 - $9.76
Previous CloseN/A
VolumeN/A
Average Volume (3M)4.77M
Market Cap
$75.81M
Enterprise Value$117.87M
Total Cash (Recent Filing)$6.22M
Total Debt (Recent Filing)$15.37M
Price to Earnings (P/E)―
Beta0.89
Next Earnings
Mar 26, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.54
Shares Outstanding139,836,520
10 Day Avg. Volume3,126,422
30 Day Avg. Volume4,771,777
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.06
Price to Sales (P/S)2.58
P/FCF Ratio-0.09
Enterprise Value/Market Cap1.55
Enterprise Value/Revenue4.75
Enterprise Value/Gross Profit12.69
Enterprise Value/Ebitda-6.92
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.6
Revenue Forecast (FY)$35.75M
Bulls Say, Bears Say
Bulls Say
WLFI Token LiquidityMaking >3.3B WLFI tokens usable as collateral and unlocking transferability materially increases funding options beyond cash flow. This provides a durable liquidity buffer to support operations, lending/staking strategies, or non-dilutive financing, reducing short-term solvency pressure over the next 2–6 months.
Stronger 2025 Balance SheetThe dramatic 2025 equity and asset increase improves solvency metrics and provides a larger capital base to absorb operating losses and fund strategic initiatives. A stronger capital structure enhances resilience and optionality, supporting medium-term execution if underlying asset values hold.
Revenue Rebound And Gross ProfitRevenue recovery and a positive gross profit indicate underlying demand for the platform and feasible unit economics at the revenue line. Sustained top-line growth and positive gross margins suggest the core business can scale profitably if operating expenses are controlled and client adoption continues.
Bears Say
Large Operating And Net LossesSubstantial operating and especially outsized net losses indicate ongoing structural profitability challenges that impair retained earnings and erode shareholder value. Persistent losses require continued external funding or asset monetization and constrain investments in product and sales capacity over the medium term.
Severe Negative Free Cash FlowDeeply negative free cash flow and a swing to negative operating cash flow signal material cash burn and funding reliance. This undermines financial flexibility, increases dilution or leverage risk if losses persist, and forces near-term management focus onto liquidity rather than long-term growth execution.
Nasdaq Bid-price Non-complianceA sustained bid-price deficiency creates structural listing risk that can impair liquidity, institutional ownership, and access to capital. Remediation (reverse split or price restoration) may alter shareholder base and distract management, with potential long-term consequences for financing and market visibility.
AI Financial Corporation News
AIFC FAQ
What was AI Financial Corporation’s price range in the past 12 months?
AI Financial Corporation lowest stock price was $0.52 and its highest was $9.76 in the past 12 months.
What is AI Financial Corporation’s market cap?
AI Financial Corporation’s market cap is $75.81M.
When is AI Financial Corporation’s upcoming earnings report date?
AI Financial Corporation’s upcoming earnings report date is Mar 26, 2027 which is in 257 days.
How were AI Financial Corporation’s earnings last quarter?
Currently, no data Available
Is AI Financial Corporation overvalued?
According to Wall Street analysts AI Financial Corporation’s price is currently Overvalued.
Does AI Financial Corporation pay dividends?
AI Financial Corporation pays a Quarterly dividend of $0.064 which represents an annual dividend yield of N/A. See more information on AI Financial Corporation dividends here
What is AI Financial Corporation’s EPS estimate?
AI Financial Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AI Financial Corporation have?
AI Financial Corporation has 139,836,520 shares outstanding.
What happened to AI Financial Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of AI Financial Corporation?
Currently, no hedge funds are holding shares in AIFC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AI Financial Corporation Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 10.3%
Last 30 Days ▼ 10.3%
News Sentiment
Bearish
Bullish news 33%
Bearish news 67%
Bearish news 67%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.55%
12-Months-Change
Fundamentals
Return on Equity
-50.06%
Trailing 12-Months
Asset Growth
1130.15%
Trailing 12-Months
Company Description
AI Financial Corporation
AI Financial Corporation, a global entity operating through its various subsidiaries, specializes in distributed ledger technology solutions. The company's activities are strategically divided into two primary segments: Fintech and Biotechnology. Its Fintech division manages the entire ecosystem of digital assets, covering everything from their initial creation (tokenization) to their trading, clearing, settlement, payment processing, and secure safekeeping. Within this sector, AI Financial offers significant products such as ALT 5 Prime, a sophisticated electronic over-the-counter (OTC) trading platform designed for the acquisition and divestiture of digital assets. Another key offering is ALT 5 Pay, a cryptocurrency payment gateway that empowers merchants to either accept and disburse payments in digital currencies directly or integrate this capability into their existing software applications. The biotechnology arm is dedicated to identifying, procuring, licensing, advancing, collaborating on, and commercializing innovative, non-opioid, and non-addictive therapeutic solutions for addressing pain and addiction. Noteworthy projects include JAN 101, an orally administered, sustained-release sodium nitrite compound that has successfully concluded Phase 2a clinical trials for the treatment of peripheral arterial disease and pain. Additionally, the company is developing JAN123, a low-dose naltrexone formulation specifically tailored for managing chronic regional pain syndrome. Established in 1976, the company is based in Las Vegas, Nevada. It officially adopted its current name, AI Financial Corporation, in April 2026, having previously been known as ALT5 Sigma Corporation.
Technical Analysis
Ownership Overview
0.04% Insiders
4.83% Mutual Funds
<0.01% Other Institutional Investors
90.84% Public Companies and
Individual Investors